Media Releases and Opportunities
» Go to news mainMedia opportunity: Dalhousie University researchers discover existing drug can disrupt coronavirus replication, offering promise of potential antiviral
When SARS-CoV-2 began its sweep across the globe, scientists set off on a daunting quest to both develop vaccines and look for ways to treat a novel coronavirus that appeared to be highly transmissible with devastating consequences.
Those efforts included an examination of existing drugs that could be repurposed to safely and effectively treat people infected with the virus that causes COVID-19.
Virologists at Dalhousie University took on that challenge, using their work researching antivirals for influenza viruses to explore drugs that could be used in the treatment of SARS-CoV-2.
In a new paper, they describe how they discovered a new effect for an FDA-approved drug known as 6-thioguanine, or 6-TG.
In cell culture experiments, they found that the drug -- normally used in cancer therapies and the treatment of irritable bowel syndrome -- can inhibit the replication of human coronaviruses, including SARS-CoV-2. It does that by interfering with the creation of the virus's hallmark spike proteins, which are needed to penetrate the host cells and initiate infection. Without them, viruses like SARS-CoV-2 cannot interact with host cells to cause infection.
Drs. Eric Pringle and Brett Duguay, two post-doctoral fellows in Dal's Faculty of Medicine, led the research and are available to discuss their findings and how they could eventually help in the development of effective, safe treatments for future coronavirus outbreaks.
-30-
Media contact:
Alison Auld
Senior Research Reporter
Communications, Marketing and Creative Services
Dalhousie University
Cell: 1-902-220-0491
Email: alison.auld@dal.ca
Recent News
- Media opportunity: Fish biomass faces steep declines by end of century under high‑emissions scenario: FAO report by Dalhousie University, international scientists
- Media Release: Two Dalhousie students selected as McCall MacBain International Fellows
- Media release: Barriers to care ‑ research reveals the experiences of transgender and gender‑diverse people seeking health care
- Media opportunity: Being involved in extracurricular activities really does matter when it comes to 'mattering': Dalhousie University research
- Media opportunity: Podcast by Dalhousie researcher and Halifax photographer looks at barriers to Nova Scotia's coastline, decreasing access to waterfronts and problems with litter, marine debris in public coastal areas
- Media opportunity: Dalhousie University researcher pioneers new cancer treatment ‑‑ cutting‑edge CAR‑T cell therapy
- Media opportunity: Research sheds light on the difficulty temporary foreign workers can face in securing permanent residency in P.E.I.
- Media opportunity: World's largest stores of unfrozen freshwater projected to warm and affect cold‑water habitats, geothermal energy resources and drinking water quality : Dalhousie University research
Comments
comments powered by Disqus